Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease.
Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease.
复制标题
DOI:
10.3389/fmed.2021.814951
复制
发表时间:
2021
影响因子:
3.9
通讯作者:
Vessby J
中科院分区:
文献类型:
--
作者:
Fridén M;Rosqvist F;Ahlström H;Niessen HG;Schultheis C;Hockings P;Hulthe J;Gummesson A;Wanders A;Rorsman F;Risérus U;Vessby J
Background: The hepatic lipidome of patients with early stages of non-alcoholic fatty liver disease (NAFLD) has been fairly well-explored. However, studies on more progressive forms of NAFLD, i.e., liver fibrosis, are limited. Materials and methods: Liver fatty acids were determined in cholesteryl esters (CE), phospholipids (PL), and triacylglycerols (TAG) by gas chromatography. Cross-sectional associations between fatty acids and biopsy-proven NAFLD fibrosis (n = 60) were assessed using multivariable logistic regression models. Stages of fibrosis were dichotomized into none-mild (F0–1) or significant fibrosis (F2–4). Models were adjusted for body-mass index (BMI), age and patatin-like phospholipase domain-containing protein 3 (PNPLA3 rs738409) (I148M) genotype. A secondary analysis examined whether associations from the primary analysis could be confirmed in the corresponding plasma lipid fractions. Results: PL behenic acid (22:0) was directly associated [OR (95% CI): 1.86 (1.00, 3.45)] whereas PL docosahexaenoic acid (22:6n-3) [OR (95% CI): 0.45 (0.23, 0.89)], TAG oleic acid (18:1n-9) [OR (95% CI): 0.52 (0.28, 0.95)] and 18:1n-9 and vaccenic acid (18:1n-7) (18:1) [OR (95% CI): 0.52 (0.28, 0.96)] were inversely associated with liver fibrosis. In plasma, TAG 18:1n-9 [OR (95% CI): 0.55 (0.31, 0.99)], TAG 18:1 [OR (95% CI): 0.54 (0.30, 0.97)] and PL 22:0 [OR (95% CI): 0.46 (0.25, 0.86)] were inversely associated with liver fibrosis. Conclusion: Higher TAG 18:1n-9 levels were linked to lower fibrosis in both liver and plasma, possibly reflecting an altered fatty acid metabolism. Whether PL 22:6n-3 has a protective role, together with a potentially adverse effect of hepatic 22:0, on liver fibrosis warrants large-scale studies.
登录
查看更多内容
影响因子:
7.1
作者:
Bjermo, Helena;Iggman, David;Riserus, Ulf
通讯作者:
Riserus, Ulf
影响因子:
2.7
作者:
Li B;Zhang C;Zhan YT
通讯作者:
Zhan YT
影响因子:
11.1
作者:
Bergström G;Berglund G;Blomberg A;Brandberg J;Engström G;Engvall J;Eriksson M;de Faire U;Flinck A;Hansson MG;Hedblad B;Hjelmgren O;Janson C;Jernberg T;Johnsson Å;Johansson L;Lind L;Löfdahl CG;Melander O;Östgren CJ;Persson A;Persson M;Sandström A;Schmidt C;Söderberg S;Sundström J;Toren K;Waldenström A;Wedel H;Vikgren J;Fagerberg B;Rosengren A
通讯作者:
Rosengren A
影响因子:
16.6
作者:
Roumans, Kay H. M.;Lindeboom, Lucas;Schrauwen-Hinderling, Vera B.
通讯作者:
Schrauwen-Hinderling, Vera B.
影响因子:
25.7
作者:
Allard, Johane P.;Aghdassi, Elaheh;Heathcote, Jenny E.
通讯作者:
Heathcote, Jenny E.